Copertina

Utilising high-dimensional data in randomised clinical trials: a review of methods and practice

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Cherlin, Svetlana, Bigirumurame, Theophile, Grayling, Michael J, Nsengimana, Jérémie, Ouma, Luke, Santaolalla, Aida, Wan, Fang, Williamson, S Faye, Wason, James M S
Natura:	Preprint
Pubblicazione:	2023
Soggetti:	Applications
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Evaluating the impact of outcome delay on the efficiency of two-arm group-sequential trials
di: Mukherjee, Aritra, et al.
Pubblicazione: (2023)

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method
di: Cherlin, Svetlana, et al.
Pubblicazione: (2020)

Evaluating the impact of outcome delay on the efficiency of sample size re-estimation
di: Mukherjee, Aritra, et al.
Pubblicazione: (2026)

Cross-validated risk scores adaptive enrichment (CADEN) design
di: Cherlin, Svetlana, et al.
Pubblicazione: (2021)

Augmented Binary Method for Basket Trials (ABBA)
di: Cherlin, Svetlana, et al.
Pubblicazione: (2024)

Optimal Bayesian stepped-wedge cluster randomised trial designs for binary outcome data
di: Etfer, Laura, et al.
Pubblicazione: (2024)

Confidence intervals for adaptive trial designs II: Case study and practical guidance
di: Robertson, David S., et al.
Pubblicazione: (2024)

Confidence intervals for adaptive trial designs I: A methodological review
di: Robertson, David S., et al.
Pubblicazione: (2024)

A systematic review of sample size determination in Bayesian randomized clinical trials: full Bayesian methods are rarely used
di: Marks, Yanara, et al.
Pubblicazione: (2025)

Evaluation of clinical utility in emulated clinical trials
di: Hruza, Johannes, et al.
Pubblicazione: (2025)

Data-driven controlled subgroup selection in clinical trials
di: Müller, Manuel M., et al.
Pubblicazione: (2025)

Equipoise calibration of clinical trial design
di: Rigat, Fabio
Pubblicazione: (2025)

Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab
di: Anwer, Sumayya, et al.
Pubblicazione: (2025)

Comparing Methods of Expert Elicitation for Treatment Effect or Borrowing Parameters in Standard and Rare Disease Clinical Trials: A Systematic Mapping Study
di: Morgan, Laura M., et al.
Pubblicazione: (2025)

Incorporating estimands into meta-analyses of clinical trials
di: Remiro-Azócar, Antonio, et al.
Pubblicazione: (2025)

Bayesian sample size determination using robust commensurate priors with interpretable discrepancy weights
di: Whitehead, Lou E., et al.
Pubblicazione: (2024)

Benchmarking covariate-adjustment strategies for randomized clinical trials
di: Shao, Yulin, et al.
Pubblicazione: (2026)

The R.O.A.D. to clinical trial emulation
di: Bertsimas, Dimitris, et al.
Pubblicazione: (2024)

Methods for non-proportional hazards in clinical trials: A systematic review
di: Bardo, Maximilian, et al.
Pubblicazione: (2023)

A novel Phase I clinical trial design with unequal cohort sizes
di: Zhu, Xiaojun
Pubblicazione: (2024)

A cautious use of auxiliary outcomes for decision-making in randomized clinical trials
di: Russo, Massimiliano, et al.
Pubblicazione: (2025)

Hybrid methods for missing categorical covariates in Cox model
di: Dioni, Abdoulaye, et al.
Pubblicazione: (2025)

Differences in Performance of Bayesian Dynamic Borrowing and Synthetic Control Methods: A Case Study of Pediatric Atopic Dermatitis
di: Cizauskas, Nicole, et al.
Pubblicazione: (2026)

Can artificial intelligence predict clinical trial outcomes?
di: Jin, Shuyi, et al.
Pubblicazione: (2024)

Bias reduction in g-computation for covariate adjustment in randomized clinical trials
di: Zhang, Xin, et al.
Pubblicazione: (2025)

Causal language jumps in clinical practice guidelines for diabetes management
di: Wang, Keling, et al.
Pubblicazione: (2025)

The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods
di: Maleyeff, Lara, et al.
Pubblicazione: (2025)

Synergy Area with FDR-controlled Evaluation (SAFE) to robustly assess safety profile in clinical trials
di: Zhan, Tianyu, et al.
Pubblicazione: (2026)

A physics and data co-driven surrogate modeling method for high-dimensional rare event simulation
di: Xian, Jianhua, et al.
Pubblicazione: (2023)

Weighting methods for truncation by death in cluster-randomized trials
di: Isenberg, Dane, et al.
Pubblicazione: (2024)

A Bayesian factor analysis model for non-randomised staggered designs
di: Schmidt, Constantin, et al.
Pubblicazione: (2025)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
di: Silva, Rebecca B., et al.
Pubblicazione: (2025)

Assurance Methods for designing a clinical trial with a delayed treatment effect
di: Salsbury, James, et al.
Pubblicazione: (2023)

Eliciting prior information from clinical trials via calibrated Bayes factor
di: Demartino, Roberto Macrì, et al.
Pubblicazione: (2024)

Adaptive L-tests for high dimensional independence
di: Zhao, Ping, et al.
Pubblicazione: (2026)

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
di: Wolbers, Marcel, et al.
Pubblicazione: (2024)

Sensitivity analysis method in the presence of a missing not at random ordinal independent variable
di: Dioni, Abdoulaye, et al.
Pubblicazione: (2025)

Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
di: Gao, Chenyin, et al.
Pubblicazione: (2024)

Multilevel functional distributional models with application to continuous glucose monitoring in diabetes clinical trials
di: Matabuena, Marcos, et al.
Pubblicazione: (2024)

One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
di: Szurewsky, Chloé, et al.
Pubblicazione: (2025)